Search PubMed⌕ Search

Biomedical subjects

M J Cooper

Publications and source records attributed to M J Cooper.

At least 181 records · Page 10Linked to original sources

The use of cloprostenol for the termination of pregnancy and the expulsion of mummified fetus in cattle.

Misalliance and mummification are two indications for treatment with cloprostenol. Of 56 animals mated accidentally that were treated with 0-5 mg cloprostenol, 12 were more than 150 days pregnant and of those, nine required more than one treatment. The animals treated early in pregnancy aborted promptly and completely whereas two, considered to be 200 days pregnant at the first treatment, failed to respond at all. There were no reports of retained fetal membranes or any adverse side effects. Eight cases of fetal mummification were also submitted for treatment. All aborted within three to five days, the fetus being removed manually per vaginam in each case. Serial blood progesterone assays indicated that successful treatment was associated with leutolysis in all cases. It was concluded that cloprostenol may successfully be used for the treatment of misalliance and mummification of the fetus.

Abortifacient Agents↗

Fluprostenol in mares: clinical trials for the treatment of infertility.

Fluprostenol (ICI 81,008) is a 16-aryloxyprostaglandin, structurally related to PGF2alpha. It is a highly potent luteolytic agent, being effective in thoroughbred mares at a single intramuscular dose of 250 mug and having a wide margin of safety in this species. A total of 941 mares have been treated with fluprostenol in an international trial, for various forms of infertility associated with abnormal persistence of luteal function. These mares were selected for treatment on the basis of clinical examination and 760 (approximately 80 per cent) responded fluprostenol by showing oestrus within seven days of the injection. The fertility of the oestrus following prostaglandin-induced luteal regression has been consistently shown to be normal. A number of causes have been identified for the lack of response in the remaining 20 per cent of animals.

Animals↗

The use of synthetic prostaglandin analogue to induce oestrus in mares.

A clinical trial involving 359 mares was conducted to ascertain the clinical value of a synthetic prostaglandin analogue (fluprostenol, ICI-81,008) structurally related to PGF2oc for treating mares in prolonged dioestrus. Some 263 mares (73.3%) displayed oestrus within 5 days of a first intramuscular injection of 250 mug fluprostenol and, of those mares later examined for pregnancy, 108 (40%) were found to have conceived during the first induced oestrus. A further 21 mares (8%) cycled normally and conceived to services during the second oestrus. Most (80.3%) of the plasma samples obtained from 242 mares prior to treatment showed a progesterone concentration greater than 1 ng/ml, thereby indicating the presence of functional luteal tissue in the ovaries. The results support earlier observations that most non-pregnant mares which fail to cycle during the breeding season are in a state of prolonged dioestrus rather than anoesturs.

Animals↗

Effects of luteolytic doses of prostaglandin F2 alpha and cloprostenol on concentrations of progesterone, luteinizing hormone, follicle-stimulating hormone, glucose, insulin, growth hormone, thyroxine, prolactin and cortisol in jugular plasma of lactating dairy cows.

Three groups of five lactating dairy cows in the mid-luteal phases of oestrous cycles were given an injection (at time 0 h) of the naturally-occurring prostaglandin F2 alpha (PGF2 alpha) or cloprostenol (a synthetic analogue of PGE2 alpha) at doses recommended for inducing luteolysis, or injection vehicle. Concentrations of glucose and hormones in jugular plasma were measured from 26 h before to 12 h after the injections and the significance (P < 0.05) of the effects of the prostaglandins on these concentrations was determined. Both prostaglandins induced falls in progesterone concentration and rises in luteinizing hormone concentration; neither influenced follicle-stimulating hormone. PGF2 alpha increased glucose concentration; neither prostaglandin influenced insulin concentration. Both prostaglandins increased growth hormone concentration and resulted in declining thyroxine concentration. PGF2 alpha increased prolactin and cortisol concentration. There were, however, no significant differences between the effects of the two prostaglandins on any hormone (or glucose) concentration.

Animals↗

Waking at night: the effect of early feeding experience.

The mothers of 180 preschool children were interviewed in their homes in a survey of feeding preferences and sleeping behaviour. We report here on the differences in current sleeping patterns and the age at which night feeds were dropped. There are clear differences in these two behaviours according to whether the baby was breast or bottle fed, and this result is not explicable in terms of social class. Night feeds disappear more slowly in the breast fed infant, and the problem of night waking both in the first year of life and when at nursery school appears to be associated with earlier breast feeding. The importance of such a finding is discussed in relation to the advice offered to mothers by health professionals.

Adult↗